The acquisition was announced in January, and Stryker purchased all of Vocera’s outstanding shares for $79.25 per share in cash. The deal is expected to have a neutral impact on Stryker’s net earnings per diluted share in 2022.
Vocera provides clinical communication and workflow products and is used in nearly 1,900 healthcare facilities. The acquisition aims to enhance Stryker’s digital healthcare business.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
